美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Paroxetine Mesylate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Patisiran Sodium	Solution	II (Paddle)	25	Tris/EDTA buffer, pH 7.5 with 0.02% Tween 20	500	2, 5, 7, 11 and 15	2023/03/30
Pazopanib HCl	Tablet	II (Paddle)	75	50 mM Sodium Acetate buffer, pH 4.5, containing 0.75% SDS	900	10, 15, 30, 45 and 60	2010/08/05
Pemigatinib	Tablet	I (Basket)	50	0.01 N HCl	500	5, 10, 15, 20, 30 and 45	2022/05/12
Pemoline	Tablet			Develop a dissolution method			2023/09/15
Penbutolol Sulfate	Tablet			Refer to USP			2010/06/24
Penicillamine	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Penicillin G Benzathine	Injectable			Develop a method to characterize in vitro release			2021/08/19
Penicillin V	Tablet			Refer to USP			2011/06/09
Penicillin V Potassium	Tablet			Refer to USP			2011/06/09
Pentosan Polysulfate Sodium	Capsule			Develop a dissolution method			2023/09/15
Pentoxifylline	Tablet (Extended Release)			Develop a dissolution method			2024/01/03
Perampanel	Suspension	II (Paddle)	50	0.1 N HCl	900 [890 mL 0.1 N HCl + 10 mL perampanel suspension]	5, 10, 15, 20 and 30	2016/12/22
Perampanel	Tablet	II (Paddle)	50	0.1 N HCl	900	5, 10, 15, 20 and 30	2014/05/15
Pergolide Mesylate	Tablet	II (Paddle)	50	Simulated gastric fluid TS with cysteine without enzymes	500	10, 20, 30 and 45	2006/03/04
Perindopril Erbumine	Tablet	II (Paddle)	50	0.1 N HCl	900	10, 20 , 30 and 45	2007/06/20
Perphenazine	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Pexidartinib Hydrochloride	Capsule	II (Paddle) with sinker	75	0.01 N HCl	900	5, 10, 15, 20, 30, 45 and 60	2026/01/28
Phendimetrazine Tartrate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Phendimetrazine Tartrate	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02